COCH Stock Summary and Trading Ideas (Envoy Medical - Class A | NASDAQ:COCH)

Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.

Envoy Medical - Class A trades on the NASDAQ stock market under the symbol COCH.

As of March 18, 2026, COCH stock price climbed to $0.84 with 404,701 million shares trading.

COCH has a beta of 0.01, meaning it tends to be less sensitive to market movements. COCH has a correlation of 0.00 to the broad based SPY ETF.

COCH has a market cap of $64.28 million. This is considered a Micro Cap stock.

Last quarter Envoy Medical - Class A reported $42,000 in Revenue and -$.35 earnings per share. This fell short of revenue expectation by $-30,000 and missed earnings estimates by -$.07.

The top ETF exchange traded funds that COCH belongs to (by Net Assets): VTI, IWC, VXF.

COCH has underperformed the market in the last year with a return of -45.4%, while SPY returned +17.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in COCH shares. However, COCH has outperformed the market in the last 3 month and 2 week periods, returning +18.9% and +22.0%, while SPY returned -1.2% and -2.8%, respectively. This indicates COCH has been having a stronger performance recently.

COCH support price is $.78 and resistance is $.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COCH shares will trade within this expected range on the day.